Healthspan Economy

ClinicalTrials.gov · NCT07220473 · Recruiting

Tirzepatide to Slow Biological Aging

Registry record

NCT07220473 on ClinicalTrials.gov. The registry's last update to this record was 24 March 2026.

Date checked: . This is the day the Atlas read the registry record; the registry may have changed since.

Verification record

5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked

  • Title as registered Tirzepatide to Slow Biological Aging Checked Source clinicaltrials.gov Brief title as registered. Checked
  • Sponsor The University of Texas Medical Branch, Galveston Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
  • Intervention Zepbound Checked Source clinicaltrials.gov Intervention names as registered. Checked
  • Primary outcome as registered Change in DNA Methylation-Based Biological Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
  • Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-03-24. Checked

Check history: NCT07220473 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.

Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.

As registered

  • Sponsor: The University of Texas Medical Branch, Galveston
  • Phase: Phase 2
  • Status: Recruiting
  • Intervention: Zepbound
  • Primary outcome: Change in DNA Methylation-Based Biological Age
  • Countries: United States
  • Start: 27 February 2026
  • Completion (estimated): January 2028

Results

No results were posted on the registry on the date checked. The Atlas does not summarize findings.

A trial being registered is not evidence that the intervention works.